Want to join the conversation?
Generic pharmaceutical company $MYL posted higher 2Q16 earnings due to higher revenues and higher gross profit. Net income was $168.4MM or $0.33 per diluted share vs. $167.8MM or $0.32 per diluted share in 2Q15. Revenue rose 8% to $2.56Bil vs. 2Q15, helped by higher third-party net sales results in its Generics and Specialty segments.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.